Day: December 13, 2019

Permanent $25 Million Series H Preferred OfferingStill Requires Shareholder ApprovalPHOENIX, AZ, Dec. 13, 2019 (GLOBE NEWSWIRE) — Taronis Technologies, Inc., (“Taronis” or “the Company”) (NASDAQ: TRNX), a sustainability technologies company, today announced a $2 million interim financing. The transaction replicates most of the key terms of the previously announced Series H convertible prefer offering, with several key differences. First, the $2 million preferred cannot convert into common stock. Second, the financing matures January 31, 2020. Lastly, the transaction includes 2 million warrants with a cash strike price of $1.00 each.“This transaction is intended as an interim financing for Taronis from several viewpoints,” commented Scott Mahoney, CEO of Taronis. “The Company has disclosed a larger $25 million offering that is subject...

BEVERLY, Mass., Dec. 13, 2019 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, is pleased to inform shareholders that the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted the Company approval to start its Phase 1 trial to investigate the use of delayed release tablets for colonic delivery of Brilacidin in healthy volunteers.A total of nine subjects will be enrolled in the trial, three subjects per cohort. Each subject will receive one treatment at one assessment visit only. In each cohort, two subjects will receive Brilacidin, and one subject will receive placebo. An expedient clinical trial, dosing of all cohorts is expected to be completed within several weeks of commencement; top-line data are anticipated within a few weeks,...

NEW YORK, Dec. 13, 2019 (GLOBE NEWSWIRE) — PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided an update on its CarpX™ first-in-human (FIH) 510(k) clinical safety study.This week, senior PAVmed personnel met with the local investigators in New Zealand and completed an on-site review of the study data. Full 90-day follow-up is now 90% complete (18 of 20 patients) and 90-day clinical follow-up is 95% complete (19 of 20 patients) – with one patient completing clinical follow-up but not yet completing electrodiagnostic testing. The research team continues to pursue the two incomplete follow-up patients. The study has, however, already exceeded the minimum 80% follow-up rate requested by the U.S. Food and Drug Administration (FDA) with no device-related...

Company announcement – No. 48 / 2019Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated personsCopenhagen, December 13, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78) has received information on transactions in Zealand’s shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons and hereby publishes the information on such transactions.Please see the attached file.For further information, please contact:Zealand Pharma Investor Relations+45 50 60 38 00 investors@zealandpharma.comLani Pollworth Morvan, Investor Relations and Communicationlpm@zealandpharma.comAbout Zealand Pharma A/SZealand Pharma A/S (Nasdaq Copenhagen and New York: ZEAL) (“Zealand”)...

ELMIRA, N.Y., Dec. 13, 2019 (GLOBE NEWSWIRE) — Chemung Financial Corporation (Nasdaq: CHMG) announced today that its Board of Directors has approved a quarterly cash dividend of $0.26 per share, payable on January 2, 2019 to common stock shareholders of record as of the close of business on December 23, 2019.Chemung Financial Corporation is a $1.8 billion financial services holding company headquartered in Elmira, New York and operates 33 retail offices through its principal subsidiary, Chemung Canal Trust Company, a full-service community bank with full trust powers.  Established in 1833, Chemung Canal Trust Company is the oldest locally-owned and managed community bank in New York State.  Chemung Financial Corporation is also the parent of CFS Group, Inc., a financial services subsidiary offering non-traditional services including...

Stockholm 2019-12-13Småa AB har tilldelats en markanvisning i Karlsviks strand, Farsta, med en preliminär byggrätt om ca 5 000 kvm BTA. Marken kommer att upplåtas som äganderätt med tillträde efter att detaljplanen har vunnit laga kraft. Inom området planerar bolaget för bostäder samt en förskola med direkt anslutning till Hökarängsbadet.Karlsviks strand är ett större utvecklingsområde som tillsammans med Telestaden och intilliggande detaljplaner utökar Farsta mot sjön Drevviken. Totalt planeras för ca 4 500 bostäder, skolor, förskolor, verksamheter och grönområden. Småa har sedan tidigare en markanvisning omfattande ca 15 000 kvm BTA inom samma detaljplan.“Vi är mycket glada över det utökade förtroendet i Karlsviks Strand, och möjligheten att bidra med ytterligare bostäder i anslutning till grönområden, spårbunden kollektivtrafik...

Company Announcement13 December 2019Announcement No. 19CFO Roland M. Andersen to leave NKT by end-June 2020The NKT Board of Directors informs that Roland M. Andersen, Chief Financial Officer of NKT A/S and NKT has decided to leave the company no later than end-June 2020.Chairman of the Board of Directors, Jens Due Olsen says:– I regret that Roland M. Andersen has decided to move on from NKT and I wish to thank him for his dedicated work since he joined in 2015. In the past four years, Roland has held a leading position in the continued transformation of the power cables company, the acquisition of ABB HV Cables and the split of NKT into two separate listed companies. Furthermore I would like to address a special thanks for taking up the position as Interim CEO until Alexander Kara joined 1 August this year.   The Board of Directors...

Selskabsmeddelelse13. december 2019Meddelelse nr. 19CFO Roland M. Andersen forlader NKT ultimo juni 2020NKT’s bestyrelse oplyser, at Roland M. Andersen, Chief Financial Officer i NKT A/S og NKT, har valgt at fratræde sin stilling senest ultimo juni 2020.Bestyrelsesformand, Jens Due Olsen, siger:– Jeg har modtaget Roland M. Andersens beslutning om at fortsætte karrieren andetsteds med beklagelse. Jeg vil gerne takke ham for sit dedikerede arbejde siden han kom til selskabet i 2015. De sidste fire år har Roland haft en ledende rolle i den fortsatte transformation af kabelforretningen, købet af ABB HV Cables og opsplitningen af NKT i to selvstændigt børsnoterede selskaber. Jeg vil desuden gerne sige en special tak for at Roland påtog sig stillingen som konstitueret CEO indtil Alexander Kara startede 1. august i år.Bestyrelsen og NKT...

Energi Danmark A/S oplyser hermed, at selskabet har underskrevet en salgsaftale med det tyske selskab Encavis AG vedr. salget af Energi Danmark A/S datterselskabet Energi Danmark Vind A/S. Energi Danmark Vind A/S blev solgt til en pris på 800 mio. DKK.Salget styrker Energi Danmark A/S kapitalberedskab og muliggør en yderligere ekspansion i de europæiske energimarkeder.